Primary Signet Ring Cell Anal Adenocarcinoma

J Gastrointest Cancer. 2012 Sep:43 Suppl 1:S168-70. doi: 10.1007/s12029-011-9338-1.

Authors

Orestis Ioannidis¹, Styliani Papaemmanouil², George Paraskevas³, Stavros Chatzopoulos⁴, Anastasios Kotronis⁴, Nikolaos Papadimitriou⁴, Apostolos Makrantonakis⁴, Emmanouil Kakoutis⁴

Affiliations

¹ , Alexandrou Mihailidi 13, 54640, Thessaloniki, Greece. [email protected].
² Department of Pathology, General Regional Hospital 'George Papanikolaou', Thessaloniki, Greece.
³ Department of Anatomy, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.
⁴ First Surgical Department, General Regional Hospital 'George Papanikolaou', Thessaloniki, Greece.

PMID: 22045275
DOI: 10.1007/s12029-011-9338-1

No abstract available

Publication types

Case Reports

MeSH terms

Aged, 80 and over
Antimetabolites, Antineoplastic / therapeutic use
Anus Neoplasms / drug therapy
Anus Neoplasms / pathology*
Anus Neoplasms / radiotherapy
Carcinoma, Signet Ring Cell / drug therapy
Carcinoma, Signet Ring Cell / pathology*
Carcinoma, Signet Ring Cell / radiotherapy
Colonoscopy
Combined Modality Therapy
Female
Fluorouracil / therapeutic use
Gastroscopy
Humans
Magnetic Resonance Imaging
Prognosis

Substances

Antimetabolites, Antineoplastic
Fluorouracil